[DOI] [PMC free article] [PubMed] [Google Scholar] 960
What Does the Human Data Actually Show
If you're considering copper peptides: start low, go slow, give it years
In some embodiments, the concentration of the cyclodextrin used in the formulations or compositions and methods disclosed herein vary according to the physiochemical properties, pharmacokinetic properties, side effect or adverse events, formulation or composition considerations, or other factors associated with the therapeutic agent, or a salt or prodrug thereof
GHK-Cu Estimated refrigerated stability: 4560+ days GHK-Cu differs significantly from most research peptides
Once mixed, the final solution should be approximately isotonic if given IV (meaning it should contain appropriate solute concentration for safety)